Has Jeffrey Chung, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,524 in general payments to Jeffrey Chung, MD across 233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Chung, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Chung, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Chung, MD

Cardiovascular Disease · New York, NYNPI 1285749960

Payments from drug & device makers

$11,524in general payments, 2019–2025

Across 233 payments — averaging $49.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$5K
Boston Scientific$2K
Biosense Webster, Inc.$1K
AstraZeneca$715
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$686
E.r. Squibb & Sons, L.L.C.$679
plus $1K from 8 others

What the payments were for

Food & beverage$11,504100%
Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	131	$5,196
Boston Scientific	30	$1,738
Biosense Webster, Inc.	30	$1,214
AstraZeneca	6	$715
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$686
E.r. Squibb & Sons, L.L.C.	6	$679
Abbott	14	$521
Janssen Scientific Affairs, LLC	2	$249
Regeneron	2	$208
Baxter Healthcare	2	$128
Amgen	1	$125
Acist Medical Systems, Inc.	1	$24
Lantheus Medical Imaging, Inc.	1	$21
CSL Behring	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,524 in reported general payments places this provider in the 80th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$159,559

Medicare patients

1,124

Services billed

2,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	590	$840,576
XareltoRivaroxaban	59	$74,546
EntrestoSacubitril/Valsartan	25	$44,368
Cardizem CdDiltiazem Hcl	16	$33,252
Metoprolol Succinate	647	$16,618
Dofetilide	20	$9,250
Diltiazem 24hr Er (Cd)Diltiazem Hcl	144	$7,217
Flecainide Acetate	53	$2,972
Amlodipine Besylate	189	$2,425
Losartan Potassium	144	$2,214
Amiodarone Hcl	95	$2,172
Atorvastatin Calcium	71	$2,164
Carvedilol	103	$1,675
Digoxin	42	$978
Olmesartan Medoxomil	15	$900

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in New York

James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Gregg StoneNew York$3.7M
Valentin FusterNew York$2.9M
Tamim NazifNew York$2.2M
Howard WeintraubNew York$1.7M
Anuradha Lala-TrindadeNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →